Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 1/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR3A | P46098 | 1/20 | 0.33 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1317639 | 0.98 | EPHX2 (0.38) | EPHX2SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL11164681 | 0.88 | SLC6A2 (0.33) | EPHX2SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL27888454 | 0.87 | EPHX2 (0.46) | EPHX2ALDH1A1 | |
| SCHEMBL2555634 | 0.86 | CHRM1 (0.41) | EPHX2SLC6A2SLC6A4SLC6A3CYP2D6 | |
| Hydrochloric Acid SCHEMBL3011881 | 0.85 | CHRM1 (0.40) | EPHX2SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL15362827 | 0.84 | SLC6A4 (0.33) | SLC6A2SLC6A4SLC6A3HTR2AHTR2C | |
| SCHEMBL17309305 | 0.84 | SLC6A4 (0.33) | SLC6A2SLC6A4SLC6A3HTR2AHTR2C | |
| SCHEMBL27389747 | 0.84 | SLC6A4 (0.33) | SLC6A2SLC6A4SLC6A3HTR2AHTR2C | |
| Hydrochloric Acid SCHEMBL3011878 | 0.83 | CHRM1 (0.42) | EPHX2SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL20133241 | 0.83 | EPHX2 (0.33) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024054956-A1 | HETEROBIFUNCTIONAL COMPOUNDS AND METHODS OF TREATING DISEASE | HALDA THERAPEUTICS OPCO, INC. (US) | 2024-03-14 | — | — | WO | disclosed |